drugset / Trial / NCT06294912
A Study to Evaluate Antimalarial Activity and Safety of MK-7602 in Healthy Adults (MK-7602-003)
RandomizedSequentialOpen-labelTreatment
Summary
The purpose of this study is to assess the antimalarial activity, pharmacokinetics, and safety of MK-7602 in healthy adults following Plasmodium falciparum (P. falciparum) infection.
Timeline
- Start
- 2024-04-18
- Primary completion
- 2025-01-06
- Completion
- 2025-01-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-7602 | Unknown | — | Oral |
| Background | Artemether | Small molecule | — | Oral |
| Background | Artesunate | Small molecule | — | Intravenous |
| Background | Atovaquone | Small molecule | — | Oral |
| Background | Primaquine | Small molecule | — | Oral |
| Background | Proguanil | Small molecule | — | Oral |
| Background | lumefantrine | Small molecule | — | Oral |